Affordable Access

deepdyve-link
Publisher Website

Chronic pulmonary aspergillosis in a tertiary care centre in Spain: A retrospective, observational study.

Authors
  • Aguilar-Company, Juan1, 2
  • Martín, María Teresa3
  • Goterris-Bonet, Lidia3
  • Martinez-Marti, Alex2
  • Sampol, Júlia4
  • Roldán, Elisa5
  • Almirante, Benito1
  • Ruiz-Camps, Isabel1
  • 1 Infectious Diseases Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. , (Spain)
  • 2 Oncology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. , (Spain)
  • 3 Microbiology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. , (Spain)
  • 4 Pneumology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. , (Spain)
  • 5 Hematology Department, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain. , (Spain)
Type
Published Article
Journal
Mycoses
Publisher
Wiley (Blackwell Publishing)
Publication Date
Sep 01, 2019
Volume
62
Issue
9
Pages
765–772
Identifiers
DOI: 10.1111/myc.12950
PMID: 31162731
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

The aim of this study was to describe the characteristics of patients with chronic pulmonary aspergillosis (CPA) in a tertiary care centre in Spain. Retrospective cohort study of all patients diagnosed with CPA between January 2010 and December 2015. The patients were identified through the Microbiology Registry. Demographic, clinical, laboratory, radiological, microbiological and clinical data were recorded. Patients were followed up for 12 months. Fifty-three patients were included; median age was 61.5 years. Forty-seven had a lung condition, 25 suffered from COPD, 19 an active malignancy, 10 had previous pulmonary tuberculosis and 9 lung interstitial disease. Twenty-eight patients presented with chronic cavitary pulmonary form (CCPA) and 20 with subacute invasive aspergillosis (SAIA). Species identified were A fumigatus (34), A niger (5), A terreus (4) and A flavus (3). All-cause 1-year mortality was 56%. Predictors of mortality were cancer history (OR, 9.5; 95% CI, 2.54-35.51; P < 0.01) and SAIA (OR, 5.49; 95% CI, 1.49-19.82; P < 0.01). Previous pulmonary tuberculosis, surgery for the treatment of CPA and CCPA were found to be associated with lower mortality (OR, 0.05; 95% CI, <0.01-0.47; P < 0.01; OR, 0.16; 95% CI, 0.03-0.88; P = 0.035 and OR 0.2, 95% CI, 0.01-0.67; P = 0.01, respectively). This is the first study providing an overview of the features of CPA in patients from Spain. CCPA was the most frequent form of CPA and A fumigatus the most frequently isolated species. Patients with cancer history and SAIA had a worse prognosis. © 2019 Blackwell Verlag GmbH.

Report this publication

Statistics

Seen <100 times